In summary, three variants located at distinct regions of the receptor can be expressed at lower levels at the top of the plasma membrane through different mechanisms, which results in IL-23R-mediated signaling and plays a protective role in IBD [133]. The gene discussed is IL23R; the disease is inflammatory bowel disease.